358 related articles for article (PubMed ID: 25987496)
1. Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Validation of Convective Thermal Energy Transfer and Characterization With Magnetic Resonance Imaging and 3-Dimensional Renderings.
Mynderse LA; Hanson D; Robb RA; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Cedano ER; Woodrum DA; Dixon CM; Larson TR
Urology; 2015 Jul; 86(1):122-7. PubMed ID: 25987496
[TBL] [Abstract][Full Text] [Related]
2. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
J Urol; 2016 May; 195(5):1529-1538. PubMed ID: 26614889
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
[TBL] [Abstract][Full Text] [Related]
4. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm(®) system: evaluation of acute ablative capabilities in the human prostate.
Dixon CM; Rijo Cedano E; Mynderse LA; Larson TR
Res Rep Urol; 2015; 7():13-8. PubMed ID: 25674555
[TBL] [Abstract][Full Text] [Related]
5. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.
McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
J Sex Med; 2016 Jun; 13(6):924-33. PubMed ID: 27129767
[TBL] [Abstract][Full Text] [Related]
6. Three-Year Outcomes of the Prospective, Randomized Controlled Rezūm System Study: Convective Radiofrequency Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
McVary KT; Roehrborn CG
Urology; 2018 Jan; 111():1-9. PubMed ID: 29122620
[TBL] [Abstract][Full Text] [Related]
7. Characterizing TUNA ablative treatments of the prostate for benign hyperplasia with gadolinium-enhanced magnetic resonance imaging.
Mynderse LA; Larson B; Huidobro C; Meyer JJ; Busel D; Hanson DP; Larson T
J Endourol; 2007 Nov; 21(11):1361-6. PubMed ID: 18042031
[TBL] [Abstract][Full Text] [Related]
8. Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis.
Haroon UM; Khan JS; McNicholas D; Forde JC; Davis NF; Power RE
Ir J Med Sci; 2022 Feb; 191(1):421-426. PubMed ID: 33599918
[TBL] [Abstract][Full Text] [Related]
9. Convective Water Vapor Energy for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.
DeLay KJ; McVary KT
Urol Clin North Am; 2016 Aug; 43(3):371-5. PubMed ID: 27476129
[TBL] [Abstract][Full Text] [Related]
10. Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
Roehrborn CG; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; McVary KT
J Urol; 2017 Jun; 197(6):1507-1516. PubMed ID: 27993667
[TBL] [Abstract][Full Text] [Related]
11. High-energy feedback microwave thermotherapy and intraprostatic injections of mepivacaine and adrenaline: an evaluation of calculated cell kill accuracy and responder rate.
Stenmark F; Brudin L; Stranne J; Peeker R
Scand J Urol; 2014 Aug; 48(4):374-8. PubMed ID: 24521182
[TBL] [Abstract][Full Text] [Related]
12. What Is New with Rezūm Water Vapor Thermal Therapy for LUTS/BPH?
Doppalapudi SK; Gupta N
Curr Urol Rep; 2021 Jan; 22(1):4. PubMed ID: 33403529
[TBL] [Abstract][Full Text] [Related]
13. Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study.
McVary KT; Rogers T; Roehrborn CG
Urology; 2019 Apr; 126():171-179. PubMed ID: 30677455
[TBL] [Abstract][Full Text] [Related]
14. Transurethral water vapor ablation of the prostate with the Rezūm system: Urodynamic findings.
Martinelli E; Cindolo L; Grossi FS; Kuczyk MA; Siena G; Oelke M
Neurourol Urodyn; 2023 Jan; 42(1):249-255. PubMed ID: 36335610
[TBL] [Abstract][Full Text] [Related]
15. Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study.
Siena G; Cindolo L; Ferrari G; Maruzzi D; Fasolis G; Condorelli SV; Varvello F; Visalli F; Rabito S; Toso S; Caroassai S; Mari A; Viola L; Somani BK; Carini M
World J Urol; 2021 Oct; 39(10):3875-3880. PubMed ID: 33787986
[TBL] [Abstract][Full Text] [Related]
16. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
17. Do Patients Treated with Water Vapor Therapy and Meeting Randomized Clinical Trial Criteria Have Better Urinary and Sexual Outcomes Than an Unselected Cohort?
Cindolo L; Campobasso D; Conti E; Uricchio F; Franzoso F; Maruzzi D; Viola L; Varvello F; Balsamo R; Ferrari G; Morselli S; Siena G
J Endourol; 2023 Mar; 37(3):323-329. PubMed ID: 36453237
[No Abstract] [Full Text] [Related]
18. Rezum to the rescue: Early outcomes of Rezum on patients with recurrent lower urinary tract symptoms after surgical interventions for benign prostatic enlargement.
Gauhar V; Lim EJ; Khan TY; Law YXT; Choo ZW; Castellani D; Teoh JY; Bhojani N; Chughtai B; Zorn K; Elterman D
Andrologia; 2022 Sep; 54(8):e14450. PubMed ID: 35474587
[TBL] [Abstract][Full Text] [Related]
19. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
20. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement.
Choi H; Kim JH; Shim JS; Park JY; Kang SH; Moon du G; Cheon J; Lee JG; Kim JJ; Bae JH
Urol Int; 2014; 93(4):425-30. PubMed ID: 25300422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
